Amalgamated Bank’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.06M | Buy |
51,334
+1,018
| +2% | +$86.5K | 0.03% | 529 |
|
|
2026
Q1 | $4.33M | Buy |
50,316
+527
| +1% | +$47.3K | 0.03% | 470 |
|
|
2025
Q4 | $4.35M | Sell |
49,789
-1,926
| -4% | -$146K | 0.03% | 475 |
|
|
2025
Q3 | $2.96M | Sell |
51,715
-150
| -0.3% | -$8.64K | 0.02% | 644 |
|
|
2025
Q2 | $3.06M | Sell |
51,865
-207
| -0.4% | -$13.4K | 0.02% | 613 |
|
|
2025
Q1 | $3.81M | Sell |
52,072
-1,712
| -3% | -$141K | 0.03% | 480 |
|
|
2024
Q4 | $4.45M | Sell |
53,784
-56
| -0.1% | -$4.42K | 0.04% | 432 |
|
|
2024
Q3 | $3.85M | Sell |
53,840
-3,053
| -5% | -$216K | 0.03% | 503 |
|
|
2024
Q2 | $3.9M | Sell |
56,893
-6,720
| -11% | -$401K | 0.03% | 545 |
|
|
2024
Q1 | $3.41M | Sell |
63,613
-11,180
| -15% | -$601K | 0.03% | 654 |
|
|
2023
Q4 | $3.99M | Sell |
74,793
-4,064
| -5% | -$198K | 0.03% | 600 |
|
|
2023
Q3 | $3.92M | Buy |
78,857
+27,092
| +52% | +$1.51M | 0.03% | 566 |
|
|
2023
Q2 | $3.08M | Sell |
51,765
-2,760
| -5% | -$157K | 0.02% | 683 |
|
|
2023
Q1 | $3.09M | Sell |
54,525
-1,904
| -3% | -$122K | 0.03% | 680 |
|
|
2022
Q4 | $4.19M | Buy |
56,429
+1,002
| +2% | +$68.2K | 0.04% | 577 |
|
|
2022
Q3 | $3.3M | Sell |
55,427
-1,166
| -2% | -$70.2K | 0.03% | 598 |
|
|
2022
Q2 | $3.18M | Buy |
56,593
+514
| +0.9% | +$33.8K | 0.03% | 665 |
|
|
2022
Q1 | $4.14M | Sell |
56,079
-1,713
| -3% | -$119K | 0.03% | 577 |
|
|
2021
Q4 | $4.17M | Buy |
57,792
+1,040
| +2% | +$75.5K | 0.03% | 608 |
|
|
2021
Q3 | $4.35M | Sell |
56,752
-5,361
| -9% | -$430K | 0.04% | 583 |
|
|
2021
Q2 | $4.82M | Buy |
62,113
+52,687
| +559% | +$3.75M | 0.04% | 572 |
|
|
2021
Q1 | $581K | Sell |
9,426
-617
| -6% | -$39.1K | 0.02% | 899 |
|
|
2020
Q4 | $655K | Buy |
10,043
+192
| +2% | +$11K | 0.02% | 805 |
|
|
2020
Q3 | $488K | Sell |
9,851
-43
| -0.4% | -$2.22K | 0.02% | 849 |
|
|
2020
Q2 | $472K | Sell |
9,894
-4,411
| -31% | -$213K | 0.02% | 869 |
|
|
2020
Q1 | $608K | Sell |
14,305
-484
| -3% | -$23.9K | 0.01% | 819 |
|
|
2019
Q4 | $871K | Buy |
14,789
+673
| +5% | +$36.5K | 0.02% | 864 |
|
|
2019
Q3 | $722K | Sell |
14,116
-218
| -2% | -$10.4K | 0.02% | 879 |
|
|
2019
Q2 | $606K | Buy |
14,334
+2,533
| +21% | +$110K | 0.01% | 975 |
|
|
2019
Q1 | $583K | Buy |
11,801
+383
| +3% | +$17.3K | 0.01% | 934 |
|
|
2018
Q4 | $494K | Buy |
11,418
+6,420
| +128% | +$320K | 0.01% | 930 |
|
|
2018
Q3 | $284K | Sell |
4,998
-6,686
| -57% | -$352K | 0.01% | 1149 |
|
|
2018
Q2 | $590K | Buy |
11,684
+1,531
| +15% | +$79.8K | 0.01% | 937 |
|
|
2018
Q1 | $506K | Sell |
10,153
-184
| -2% | -$8.65K | 0.01% | 954 |
|
|
2017
Q4 | $425K | Buy |
10,337
+616
| +6% | +$21.6K | 0.01% | 1078 |
|
|
2017
Q3 | $289K | Sell |
9,721
-441
| -4% | -$13.5K | 0.01% | 1233 |
|
|
2017
Q2 | $337K | Buy |
10,162
+511
| +5% | +$16.1K | 0.01% | 1128 |
|
|
2017
Q1 | $286K | Sell |
9,651
-12
| -0.1% | -$328 | 0.01% | 1164 |
|
|
2016
Q4 | $240K | Buy |
+9,663
| New | +$220K | 0.01% | 1279 |
|
Other funds holding GMED
BTW
GCM
AP
SIMG
ACA
AIM
Amalgamated Bank's GMED Position: Q2 2026 in Review
Amalgamated Bank increased its Globus Medical (GMED) stake by 2% in Q2 2026, buying an estimated $86.5K and bringing the position to 51,334 shares worth $4.06M. The position accounts for 0.03% of the portfolio, ranked #529.
Amalgamated Bank first reported a position in GMED in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.82M in Q2 2021. 295 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Amalgamated Bank held 51,334 shares of Globus Medical worth $4.06M as of Q2 2026.
- Amalgamated Bank bought 1,018 Globus Medical shares in Q2 2026, an estimated $86.5K.
- Globus Medical made up 0.03% of Amalgamated Bank's portfolio in Q2 2026, its #529 holding.
- Amalgamated Bank first reported a position in Globus Medical in Q4 2016 and has held it in 39 quarters since.
- Amalgamated Bank's Globus Medical position peaked at $4.82M in Q2 2021.
- 295 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.